Skip to main content
. 2023 Jan 10;12(1):110. doi: 10.3390/biology12010110

Table 2.

Extracellular matrix–vesicle interaction.

Scene Events Ref.
1. Around
producer cells
a. CAFs and cancer cells are major producers of matrix proteins. [51,52]
b. EVs are embedded within ECM and accumulated around producer cells. [70]
c. EVs and ECM mutually promote their accumulation around cells. [70]
d. sEVs act similar to car wheels to help cells migrate on rails of fibronectin. [71]
e. MMPs cleave matrix proteins to release matrix vesicles, growth factors, and chemokines. [72]
f. MMPs destroy ECM to increase the accessibility of proteins, EVs, and drugs to target cells. [70]
2. In bodily fluids
(or tissue culture
supernatant)
a. EVs are often coated with matrix (fibronectin, proteoglycan, agrin, tenascin, hyaluronan). [64,73]
b. EV surface MMPs promote the dissemination of EVs. [7]
3. At niches
(at local and
distant tissues)
a. EV surface integrins bind to ECM, leading to niche formation. [74]
b. EV surface matrices bind to ECM on the surface of recipient cells. [75]
c. EV surface growth factors, cytokines and chemokines determine uptake and bio distribution. [76]
d. MMPs loaded in EVs are transferred into recipient cell nuclei and transactivate the CCN2 gene, encoding a matricellular protein. [7]
e. EV surface MMPs promote the penetration of EVs into target tissues. [8]